Literature DB >> 519105

Incorporation and metabolism of [14C]-arachidonic acid in guinea-pig lungs.

P J Jose, J P Seale.   

Abstract

1 Following infusion of [(14)C]-arachidonic acid into guinea-pig isolated lungs more than half the administered radioactivity was retained by the lung.2 The majority of the retained radioactivity was present in the phospholipid fraction with lesser amounts in the neutral lipid and free fatty acid fractions. When fatty acid methyl esters of the phospholipid fraction were prepared, 80% of the radioactivity co-chromatographed with methyl arachidonate.3 Transformation to cyclo-oxygenase products and subsequent emergence in lung effluent accounted for approximately 20% of infused radioactivity.4 After pretreatment of lungs with [(14)C]-arachidonic acid, stimulation of arachidonic acid metabolism with injections of partially purified slow-reacting substance of anaphylaxis (SRS-A), bradykinin or antigen challenge released rabbit aorta contracting substance (RCS) and prostaglandin-like substances (PGLS) but little radioactivity. Furthermore, repeated injections of SRS-A or bradykinin released similar amounts of RCS and PGLS but diminishing amounts of radioactivity.5 These data indicated that exogenous arachidonic acid was taken up by the lung and incorporated into phospholipids. However, this newly incorporated arachidonic acid had not equilibrated with the pool activated by SRS-A, bradykinin and antigen challenge for conversion to cyclo-oxygenase products.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519105      PMCID: PMC2043905          DOI: 10.1111/j.1476-5381.1979.tb08697.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE.

Authors:  H P RANG
Journal:  Br J Pharmacol Chemother       Date:  1964-04

2.  Release of slow-reacting substance from guinea-pig and human lung by calcium ionophore A23187 [proceedings].

Authors:  P J Piper; J P Seale
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

3.  Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung.

Authors:  W Dawson; J R Boot; A F Cockerill; D N Mallen; D J Osborne
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

4.  Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.

Authors:  B A Jakschik; S Falkenhein; C W Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

5.  Release of prostaglandins and rabbit aorta contracting substance (RCS) from guinea-pig lung by slow reacting substance of anaphylaxis (SRS-A) [proceedings].

Authors:  D M Engineer; P J Piper; P Sirois
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

6.  Fate of arachidonic acid in guinea-pig isolated lungs [proceedings].

Authors:  F Al-Ubaidi; Y S Bakhle; P J Jose; J P Seale
Journal:  J Physiol       Date:  1978-08       Impact factor: 5.182

7.  Hormonal stimulation of arachidonate release from isolated perfused organs. Relationship to prostaglandin biosynthesis.

Authors:  P C Isakson; A Raz; S E Denny; A Wyche; P Needleman
Journal:  Prostaglandins       Date:  1977-11

8.  Selective incorporation of 14C-arachidonic acid into the phospholipids of intact tissues and subsequent metabolism to 14C-prostaglandins.

Authors:  P C Isakson; A Raz; P Needleman
Journal:  Prostaglandins       Date:  1976-11

9.  Involvement of endoperoxides and thromboxanes in anaphylactic reactions.

Authors:  M Hamberg; J Svensson; P Hedqvist; K Strandberg; B Samuelsson
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

10.  Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.

Authors:  D M Engineer; U Niederhauser; P J Piper; P Sirois
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

View more
  6 in total

1.  Cationic factors affecting phospholipase activities from human lung.

Authors:  D A Yeats; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

Review 2.  How is the level of free arachidonic acid controlled in mammalian cells?

Authors:  R F Irvine
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

3.  Anti-inflammatory effect of LA 2851 and reference drugs on some models of inflammation. Investigation of the mechanism of action.

Authors:  J L Junien; C Lakatos; J Brohon; M Guillaume; J Sterne
Journal:  Agents Actions       Date:  1982-10

4.  Bradykinin-stimulated prostaglandin E2 production by endothelial cells and its modulation by antiinflammatory compounds.

Authors:  P J Jose; D A Page; B E Wolstenholme; T J Williams; D C Dumonde
Journal:  Inflammation       Date:  1981-12       Impact factor: 4.092

5.  Effects of the oestrous cycle on the metabolism of arachidonic acid in rat isolated lung.

Authors:  Y S Bakhle; J T Zakrzewski
Journal:  J Physiol       Date:  1982-05       Impact factor: 5.182

6.  Oxidative transformations of arachidonic acid in human dispersed lung cells: disparity between the utilization of endogenous and exogenous substrate.

Authors:  J Harvey; S T Holgate; B J Peters; C Robinson; J R Walker
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.